Product Name :
Repaglinide D5
Description:
Repaglinide D5 (AG-EE 623ZW D5) is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus.
CAS:
1217709-85-7
Molecular Weight:
457.62
Formula:
C27H36N2O4
Chemical Name:
2-[(1,1,2,2,2-²H₅)ethoxy]-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid
Smiles :
[2H]C([2H])([2H])C([2H])([2H])OC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O
InChiKey:
FAEKWTJYAYMJKF-NTSVIFQKSA-N
InChi :
InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1/i1D3,4D2
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Abacavir} MedChemExpress|{Abacavir} Telomerase|{Abacavir} Protocol|{Abacavir} In Vitro|{Abacavir} supplier|{Abacavir} Epigenetic Reader Domain}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Repaglinide D5 (AG-EE 623ZW D5) is deuterium labeled Repaglinide.{{Ajmaline} MedChemExpress|{Ajmaline} Sodium Channel|{Ajmaline} Biological Activity|{Ajmaline} Description|{Ajmaline} supplier|{Ajmaline} Cancer} Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus.|Product information|CAS Number: 1217709-85-7|Molecular Weight: 457.62|Formula: C27H36N2O4|Chemical Name: 2-[(1,1,2,2,2-²H₅)ethoxy]-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid|Smiles: [2H]C([2H])([2H])C([2H])([2H])OC1=CC(CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(O)=O|InChiKey: FAEKWTJYAYMJKF-NTSVIFQKSA-N|InChi: InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1/i1D3,4D2|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.PMID:23543429 |Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Repaglinide reduces postprandial glucose levels by enhancing the early phase of insulin secretion and increasing the total amount of insulin secreted.|Products are for research use only. Not for human use.|